|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/62 | |
| A61K 38/28 |
| (11) | Patento numeris | 2910571 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14198514.3 |
| Europos patento paraiškos padavimo data | 2009-03-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-10-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 08102708 | 2008-03-18 | EP | |
| 08170231 | 2008-11-28 | EP |
| (72) |
Hoeg-Jensen, Thomas, DK
Tagmose, Tina M ller, DK
Kjeldsen, Thomas B rglum, DK
Glendorf, Tine, DK
Garibay, Patrick W., DK
Madsen, Peter, DK
Jakobsen, Palle, DK
Kodra, Jįnos Tibor, DK
Petersen, Jacob Sten, DK
|
| (73) |
Novo Nordisk A/S,
Corporate Patents Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES |
| PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES |